FDA
-
-
-
-
-
-
-
Bausch + Lomb Corporation (BLCO) Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens
-
-
-
-
-
-
-
Emergent BioSolutions (EBS) Appoints Industry Leader Joseph C. Papa as New President and CEO
-
-
-
-
-
-
-
Bausch + Lomb Launches MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) in the United States
-
-
-
-
-
-
-
Bausch + Lomb and Novaliq Announce FDA Approval of MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) for the Treatment of the Signs and Symptoms of Dry Eye Disease
-
-
-
-
-
-
-
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2022 Results
-
-
-
-
-
-
-
Bausch + Lomb and Novaliq Announce Publication of Pivotal Phase 3 Data on NOV03 (Perfluorohexyloctane) in Ophthalmology
-
-
-
-
-
-
-
Bausch + Lomb Will Present New Scientific Data and Analyses During the American Academy of Ophthalmology Annual Meeting
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

